Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan DOI Creative Commons
Ahmad Al‐Azayzih, Anan S. Jarab,

Enas Bani-Ahmad

et al.

Saudi Pharmaceutical Journal, Journal Year: 2023, Volume and Issue: 31(9), P. 101710 - 101710

Published: July 27, 2023

Geriatric cancer patients are susceptible to adverse drug events due the complexity of their chemotherapy regimens and collateral treatments for comorbid conditions. Prescribing medications with anticholinergic burden characteristics can complicate condition, leading negative impacts on health outcomes quality life, including an increase in event frequency, physical cognitive impairments.This study aims examine prevalence prescribing identify cumulative load risk associated drugs prescribed elderly patients. Also, predictors that might lead raised these patients.This retrospective cross-sectional included (age ≥ 65) diagnosed admitted adult oncology unit at King Abdullah University Hospital (KAUH) Jordan during period between (January 1st, 2019, January 2022). The medication charts 420 were evaluated outcomes.Of total subjects, females represented 49.3%, average age was 72.95 (SD = 7.33). A 354 (84.3%) least one carrying properties. Median 3 (IQR 4). Our found 194 (46.2%) a high (cumulative score 3). Metoclopramide, furosemide, tramadol most frequently Alimentary tract action commonly encountered items our population.Our revealed significantly among Nearly half developing serious effects related activity from administered. Polypharmacy strongly increased score. Evidence-based recommendations utilizing strategies safer alternatives deprescribing inappropriate could reduce such prescribing.

Language: Английский

Association of the Drug Burden Index (DBI) exposure with outcomes: A systematic review DOI Creative Commons

Bonnie M. Liu,

Lisa Kouladjian O’Donnell, Mitchell R. Redston

et al.

Journal of the American Geriatrics Society, Journal Year: 2023, Volume and Issue: 72(2), P. 589 - 603

Published: Nov. 25, 2023

Abstract Background The Drug Burden Index (DBI) measures an individual's total exposure to anticholinergic and sedative medications. This systematic review aimed investigate the association of DBI with clinical prescribing outcomes in observational pharmaco‐epidemiological studies, effect on functional pre‐clinical models. Methods A search nine electronic databases, citation indexes gray literature was performed (April 1, 2007–December 31, 2022). Studies that reported primary data or conducted any setting humans aged ≥18 years animals were included. Quality assessment using Joanna Briggs Institute critical appraisal tools Systematic Review Centre for Laboratory animal Experimentation risk bias tool. Results Of 2382 studies screened, 70 met inclusion criteria (65 humans, five animals). In included function ( n = 56), cognition 20), falls 14), frailty 7), mortality 9), quality life 8), hospitalization length stay 5), readmission 1), other 15) 2). higher significantly associated increased (11/14, 71%), poorer (31/56, 55%), (11/20, 55%) related outcomes. Narrative synthesis used due significant heterogeneity study population, setting, type, definition DBI, outcome measures. could not be pooled heterogeneity. animals, 18), 2), 1). a caused frailty. Conclusions may decreased cognition. Higher inconsistently mortality, stay, frailty, reduced life. Human findings respect are supported by preclinical interventional studies. as tool identify older adults at harm.

Language: Английский

Citations

17

Setting of initiation and factors associated with antidepressant use on entry to long‐term care facilities DOI Creative Commons
Georgina A. Hughes, Maria C. Inacio, Debra Rowett

et al.

British Journal of Clinical Pharmacology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 31, 2025

Abstract Aims Antidepressant use increases around long‐term care facility (LTCF) entry, and initiation during hospitalizations may contribute to this. This study characterized the setting (i.e., community‐based, hospital or LTCF) where antidepressants were initiated determined associated resident characteristics. Methods A cross‐sectional including non‐Indigenous individuals aged 65–105 years who entered LTCFs in two Australian states 2015–2019, dispensed an antidepressant within 2 months, was conducted. Care settings (community‐based, from linked LTCF records, ≤30 days before entry. Pharmaceutical claims after entry screened determine initiation. Multivariate multinomial logistic regression estimated adjusted odds ratios (aORs) 95% confidence intervals (95% CIs) for characteristics with of Results included 34 525 residents 1046 LTCFs. Overall, 27 160 (78.7%) commenced prior 2552 (7.4%) 4813 (13.9%) Mirtazapine constituted 44.8% ( n = 1143) hospitals 39.5% 1902) Residents ≥90 more likely start compared community‐based (aOR 1.97, CI 1.74–2.23). recently using a psychotropic LTCF. Conclusions Individuals receiving transition are often already taking Future interventions optimize should consider setting, recency indication initiation, ongoing monitoring safety.

Language: Английский

Citations

0

Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan DOI Creative Commons
Ahmad Al‐Azayzih, Anan S. Jarab,

Enas Bani-Ahmad

et al.

Saudi Pharmaceutical Journal, Journal Year: 2023, Volume and Issue: 31(9), P. 101710 - 101710

Published: July 27, 2023

Geriatric cancer patients are susceptible to adverse drug events due the complexity of their chemotherapy regimens and collateral treatments for comorbid conditions. Prescribing medications with anticholinergic burden characteristics can complicate condition, leading negative impacts on health outcomes quality life, including an increase in event frequency, physical cognitive impairments.This study aims examine prevalence prescribing identify cumulative load risk associated drugs prescribed elderly patients. Also, predictors that might lead raised these patients.This retrospective cross-sectional included (age ≥ 65) diagnosed admitted adult oncology unit at King Abdullah University Hospital (KAUH) Jordan during period between (January 1st, 2019, January 2022). The medication charts 420 were evaluated outcomes.Of total subjects, females represented 49.3%, average age was 72.95 (SD = 7.33). A 354 (84.3%) least one carrying properties. Median 3 (IQR 4). Our found 194 (46.2%) a high (cumulative score 3). Metoclopramide, furosemide, tramadol most frequently Alimentary tract action commonly encountered items our population.Our revealed significantly among Nearly half developing serious effects related activity from administered. Polypharmacy strongly increased score. Evidence-based recommendations utilizing strategies safer alternatives deprescribing inappropriate could reduce such prescribing.

Language: Английский

Citations

1